Literature DB >> 26434787

The influence of cancer on endocrine, immune, and behavioral stress responses.

Leah M Pyter1.   

Abstract

Tumors perturb various physiological systems beyond their local microenvironment, including the immune, nervous, and metabolic systems. Given the involvement of these systems in physiological stress responses, the goal of this review is to compile evidence regarding whether or not cancer alters acute stress responses. Here, we focus on stress responses that are endocrine, immune, or behavioral. This question is clinically relevant as cancer patients are exposed to many stressors throughout diagnosis and treatment, and then later as survivors. Alterations in their stress responses may specifically affect how they respond to advice, treatments, and surgery under duress. To determine whether tumors alone alter stress responses, the relevant literature using rodent cancer models is first reviewed. Next, the more complicated clinical literature in cancer patients is integrated into the discussion. Based on the results of this analysis, goals for future basic and clinical research are proposed. This work aims to advance our understanding of the most effective methods for treating cancer patients and supporting their long-term survival.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer survivors; Glucocorticoids; Hypothalamic-pituitary-adrenal axis; Tumor

Mesh:

Year:  2015        PMID: 26434787     DOI: 10.1016/j.physbeh.2015.09.031

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  10 in total

1.  Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation.

Authors:  Leah M Pyter; Lorena P Suarez-Kelly; William E Carson; Jasskiran Kaur; Joshua Bellisario; Savannah R Bever
Journal:  Behav Brain Res       Date:  2017-05-04       Impact factor: 3.332

2.  Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.

Authors:  A M Anusa; Rooban Thavarajah
Journal:  J Oral Biol Craniofac Res       Date:  2019-03-13

Review 3.  Screening for distress in patients with primary brain tumor using distress thermometer: a systematic review and meta-analysis.

Authors:  Fangkun Liu; Jing Huang; Liyang Zhang; Fan Fan; Jindong Chen; Kun Xia; Zhixiong Liu
Journal:  BMC Cancer       Date:  2018-02-02       Impact factor: 4.430

Review 4.  Immune-Neuroendocrine Interactions: Evolution, Ecology, and Susceptibility to Illness.

Authors:  Johanna M C Blom; Enzo Ottaviani
Journal:  Med Sci Monit Basic Res       Date:  2017-11-16

Review 5.  Mechanisms of Neurotoxic Symptoms as a Result of Breast Cancer and Its Treatment: Considerations on the Contribution of Stress, Inflammation, and Cellular Bioenergetics.

Authors:  Tamara E Lacourt; Cobi J Heijnen
Journal:  Curr Breast Cancer Rep       Date:  2017-04-22

Review 6.  Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments.

Authors:  Jessica C Santos; Leah M Pyter
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

7.  Tumor resection ameliorates tumor-induced suppression of neuroinflammatory and behavioral responses to an immune challenge in a cancer survivor model.

Authors:  Jessica C Santos; Savannah R Bever; Gabriela Pereira-da-Silva; Leah M Pyter
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

8.  Functioning of autobiographical memory specificity and self-defining memories in people with cancer diagnosis.

Authors:  Marta Nieto; Beatriz Navarro-Bravo; Beatriz Moreno; Alberto Ocana; Juan Pedro Serrano; Clotilde Boix Gras; Jorge Ricarte; Luz Fernández-Aguilar; Laura Ros; Jose Miguel Latorre
Journal:  PeerJ       Date:  2019-12-19       Impact factor: 2.984

9.  Psychological stress and pancreatic cancer patients: a qualitative systematic review protocol.

Authors:  Ann M Mazzella Ebstein; Simi Jesto Joseph; Marisol Hernandez
Journal:  JBI Evid Synth       Date:  2020-03

Review 10.  Dimethyl-Benz(a)anthracene: A mammary carcinogen and a neuroendocrine disruptor.

Authors:  Bernard Kerdelhué; Claude Forest; Xavier Coumoul
Journal:  Biochim Open       Date:  2016-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.